Isabel Frahm
1 Papers
Isabel Frahm is an academic researcher. The author has contributed to research in topics: Cancer & Breast cancer. The author has co-authored 1 publications.
Chat about Author
Papers
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
Khalid El Bairi,Harry R Haynes,Harry R Haynes,Elizabeth F Blackley,Susan Fineberg,Jeffrey Shear,Sophia Turner,Juliana Ribeiro de Freitas,Daniel Sur,Luis Claudio Amendola,Masoumeh Gharib,Amine Kallala,Indu Arun,Farid Azmoudeh-Ardalan,Luciana Fujimoto,Luz F. Sua,Shi-Wei Liu,Huang-Chun Lien,Pawan Kirtani,Marcelo Luiz Balancin,Hicham El Attar,Prerna Guleria,Wenxian Yang,Emad Shash,I-Chun Chen,Veronica Bautista,Jose Fernando Do Prado Moura,Bernardo Leon Rapoport,Carlos A. Castaneda,Eunice Spengler,Gabriela Acosta-Haab,Isabel Frahm,Joselyn Sanchez,Miluska Castillo,Najat Bouchmaa,Reena R Md Zin,Ruohong Shui,Timothy Onyuma,Wentao Yang,Zaheed Husain,Karen Willard-Gallo,An Coosemans,Edith A. Perez,Elena Provenzano,Paula Gonzalez Ericsson,Eduardo Richardet,Ravi Mehrotra,Sandra Sarancone,Anna Ehinger,David L. Rimm,John M. S. Bartlett,John M. S. Bartlett,John M. S. Bartlett,Giuseppe Viale,Carsten Denkert,Akira I Hida,Christos Sotiriou,Sibylle Loibl,Stephen M. Hewitt,Sunil Badve,William Fraser Symmans,Rim S Kim,Giancarlo Pruneri,Shom Goel,Shom Goel,Prudence A. Francis,Prudence A. Francis,Gloria Inurrigarro,Rin Yamaguchi,Hernán García-Rivello,Hugo M. Horlings,Said Afqir,Roberto Salgado,Sylvia Adams,Marleen Kok,Maria Vittoria Dieci,Stefan Michiels,Sandra Demaria,Sherene Loi,Sherene Loi +79 more
- 01 Dec 2021
TL;DR: In this paper, a review from the International Immuno-Oncology Biomarker Working Group discusses the biological understanding of TILs, their analytical and clinical validity and efforts toward the clinical utility in BC, and the current status of PD-L1 and TIL testing across different continents, including experiences from low-to-middle-income countries, incorporating also the view of a patient advocate.
159